axitinib
Axitinib is an indazole derivative. It is most commonly marketed under the name Inlyta® and is available in oral formulations._x000D_ Axitinib is a second generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3).7. Reference standards of Axitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Axitinib N-Glucuronide
[catalogue_number] => PA 28 45560
[category_ids] => ,70,78,80,81,82,88,95,
[chemical_name] =>
[weight] => 562.59
[form] => C28H26N4O7S
[cas] => NA
[pslug] => axitinib-n-glucuronide-pa2845560
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 28 45560
Molecular Formula : C28H26N4O7S
Molecular Weight : 562.59